Navigating the World of OTC Hearing Aids
Intro by Bridget Dobyan, HIA Director of Public Policy & Advocacy
If you’re a regular reader of our blogs or turn on the news from time to time, you know that there is now another pathway available to addressing your hearing loss. In October 2022, a rule creating a new category of hearing aids known as “over-the-counter hearing aids” or “OTC hearing aids” became effective. OTC hearing aids are intended for use by adults (age 18 or over) with perceived mild to moderate hearing loss. All other hearing aids, now called “prescription hearing aids,” are available through a licensed hearing professional and are appropriate for all levels of hearing loss.
With the new OTC hearing aid category offering additional avenues to select and purchase hearing aids, navigating your hearing health can become overwhelming. If you think you may have hearing loss, it is still best to first see a licensed hearing professional, such as an audiologist or hearing aid specialist. Hearing professionals can test your hearing, help you understand the impact of treating your hearing loss, provide advice, answer questions, and review the options that are available to you.
If you’re like me, you also like to do your own research before making a purchase. There is a lot of information out there about OTC hearing aids, prescription hearing aids, and the new landscape for treating hearing loss. FDA provides a device classification database that includes medical device manufacturers registered with FDA and devices listed with FDA, including OTC hearing aids. To search for establishment registrations and device listings, visit the FDA’s Establishment Registration & Device Listing database. You can search using the name of the establishment, owner, name, product code, and more. Searchable hearing aid product codes include:
To help keep it all straight, our friends over at Hearing Tracker have put together a list of OTC hearing aids, distinctions within the new OTC category, and FDA product codes. Read on to learn about the options currently listed with the FDA, features that devices may offer based on product codes, new partnerships in the hearing health space, and more.
In the old world, there were two main categories of prescription air-conduction hearing aids:
Hearing aids falling within these two categories are intended for sale by state-licensed audiologists and hearing instrument dispensers. While the FDA does not require registrants to prove the effectiveness of their hearing aids, manufacturers do have to comply with standards for electrical safety, electroacoustic performance, biocompatibility, and bench verification testing. The primary difference between the two categories is that the latter, with its wireless transmissions and functionality, have additional requirements for electromagnetic and immunity testing.
In the new world of hearing aids, we still have the above existing categories, but also get a third group of self-fitting air conduction hearing aids:
“Self-fitting” in this context simply means a wearable amplification device containing technology (e.g., software) that allows users with mild-to-moderate hearing loss to program their own devices. The technology takes the user's input and enables them to customize or select settings independently, rather than relying on a professional to be fitted.
This means the manufacturer must make the "tools, test, or software" easy to set up for the end user. The FDA has, thankfully, set a higher bar for manufacturers that wish to register their hearing aids as programmable. A user study must be performed to prove that the device can be used by consumers as intended and that the device is safe and effective.
Products that fall under the FDA's Section 874.3325 can all be sold directly to consumers, but there are two subclasses that dictate where the products can be sold, exactly:
QDD was created in 2018 when the FDA granted de novo (new product category) status to the first Bose self-fitting hearing aid—a device that would never actually be sold commercially but was still subject to labeling and performance requirements. In effect, that product was the only air-conduction non-wireless hearing aid from that point forward to require 510(k) approval.
With the FDA's issuance of its Final Rules for OTC hearing aids in August 2022, the Agency essentially reorganized air-conduction hearing aids, keeping all of the original categories (including 874.3300 [ESD], 874.3305 [OSM] and 874.3325 [QDD]) and their existing product codes. For those that met the Final Rule requirements for OTC, a “new” product code was issued under each of the regulations for OTC intended use. The previous product codes were maintained but (effective October 2022) were designated as prescription devices while the “new” product codes (QUF, QUG, and QUH) became the OTC versions of the same three listed above (874.3300 , -.3305, and -.3325).
For simplicity's sake, you can think of the big difference between QDD and QUH as being the labeling requirements. In the case of QUH (the OTC variety), product boxes will need to have very specific information about the intended use, risks, and contraindications of OTC hearing aids.
We will also see a new product classifications for the old wireless (874.3305) and non-wireless (874.3300) air-conduction hearing aids:
In defining "self-fitting" vs "preset-based", the FDA states that "a hearing aid outputting a preset likely would not be self-fitting, but a hearing aid that allowed the user to make frequency dependent modifications to a preset to suit the user’s preferences likely would be self-fitting."
Generally speaking, an OTC hearing aid that uses testing and fitting software to measure your hearing ability at several frequencies (pitches) and then program the aid accordingly will be more precise than an OTC hearing aid that simply uses a series of presets designed to correct for an “average hearing loss” type. For some people with milder forms of hearing loss, this distinction may not be as critical. However, if you have moderate hearing loss and/or more complex hearing needs, then you'll likely get better performance from a self-fitting hearing aid that can be programmed for your own unique hearing profile (i.e., having the volume adjusted in each available frequency).
Another major difference between OTC self-fitting and preset-based hearing aids is that the FDA does not require the same rigorous testing of preset-based hearing aids. And from a manufacturer's standpoint, it's much easier and less expensive to build a simple hearing aid with presets than a more sophisticated software-based device—meaning this product class is more likely to attract companies looking to make a quick buck. Having said this, there are sure to be some good pre-set products. Just proceed more cautiously if you purchase a QUG- or QUF-classified hearing aid.
That's a lot to take in. Here's a helpful cheat sheet of all the product codes discussed (OSM discussed in the section about Eargo, below):
Product Code | Regulation Number | OTC | Description |
---|---|---|---|
QUF | 874.3300 | Yes | Preset-based OTC hearing aid, air-conduction |
QUG | 874.3305 | Yes | Preset-based OTC hearing aid, air-conduction with wireless technology |
QDD | 874.3325 | No | Self-fitting hearing aid that may be sold online |
QUH | 874.3325 | Yes | Wireless self-fitting OTC hearing aid that may be sold online AND in stores, pharmacies, etc. |
OSM | 874.3305 | No | Prescription wireless air-conduction hearing aids |
Without further ado, here's the comprehensive list of hearing aids that are registered with the FDA as self-fitting or preset-based, based on the three product codes discussed above:
Product | Company | Regulation Number | Product Code |
---|---|---|---|
Bose SoundControl Hearing Aids | Bose Corporation | 874.3325 | QDD |
BHA100 Series Braun Clear Hearing Aid | Kaz USA Inc. a Helen of Troy Company | 874.3325 | QDD |
Jabra Enhance Plus | GN Hearing A/S | 874.3325 | QDD |
MDHearingAid app MDHearingAid Smart hearing aids | MDHearingAid | 874.3325 | QDD |
Vibe SF Self-Fitting Hearing Aid | WSAUD A/S | 874.3325 | QDD |
Nuheara IQbuds 2 PRO Hearing Aid | Nuheara Limited | 874.3325 | QUH |
Lucid® 7495* | HEARING LAB TECHNOLOGY, LLC | 874.3305 | QUG |
NuvoMed HNB-4/0143 | NUVOMED, INC. | 874.3305 | QUG |
AcoSound Leya-W-RIC-S* | Hangzhou AcoSound Technology Co.,Ltd. | 874.3305 | QUG |
AcoSound Celesto-W-BTE-M | Hangzhou AcoSound Technology Co.,Ltd. | 874.3305 | QUG |
Hearing Assist CONNECT | Hearing Assist II, Inc. | 874.3305 | QUG |
Hearing Assist CONTROL | Hearing Assist II, Inc. | 874.3305 | QUG |
Hearing Assist STREAM | Hearing Assist II, Inc. | 874.3305 | QUG |
otoTune™ app* | Soundwave Hearing, LLC | 874.3305 | QUG |
Soundwave Hearing* | Soundwave Hearing, LLC | 874.3305 | QUG |
Sontro™ Hearing Aids* | Soundwave Hearing, LLC | 874.3305 | QUG |
Austar BTE-OE | Austar Hearing Science & Technology (Xiamen) Co. | 874.3300 | QUF |
Enlite, Enlite Plus | Etymotic Research, Inc | 874.3300 | QUF |
Air-Conduction Hearing Aid | Foshan Vohom Technology Co | 874.3300 | QUF |
Multiple products** | Hangzhou Acosound Technology Ltd | 874.3300 | QUF |
HearingAssist EAZE | Hearing Assist II LLC | 874.3300 | QUF |
Enrich, Enrich Pro, Enlite, Enlite Plus | Hearing Lab Technology LLC | 874.3300 | QUF |
Go Hearing Lite, Go Hearing Prime, Go Lite, Go Prime | HearX SA / HearX USA | 874.3300 | QUF |
Multiple products** | Hong Yu Kang Technology | 874.3300 | QUF |
Multiple products** | Huizhou Jinghao Medical Technology Co | 874.3300 | QUF |
XPLORE | Innerscope Hearing Technologies Inc | 874.3300 | QUF |
Multiple products** | Kunwei Medical Electronics Co | 874.3300 | QUF |
Air3, NEO, Volt, Air, Control, Lux, Pro, Volt+ | MDHearingAid | 874.3300 | QUF |
Sound World Solutions HD75, HD75R | Nantsound, Inc | 874.3300 | QUF |
"Hearing Aid" | Nuvomed, Inc | 874.3300 | QUF |
"Hearing Aid" | Shenzhen Zhongde Audio-Technical Co | 874.3300 | QUF |
Multiple products** | Tomore Medical (Shenzhen) Co. | 874.3300 | QUF |
Multiple products** | Xiamen Melosound Technology Co | 874.3300 | QUF |
Multiple products** | Xiamen Mirasing Technology Co | 874.3300 | QUF |
Multiple products** | Xiemen Newsound Technology Co | 874.3300 | QUF |
Multiple products** | Xiemen Retone Hearing Technology Co | 874.3300 | QUF |
Multiple products** | Xiamen Wenatone Medical Technology Co | 874.3300 | QUF |
Multiple products** | Xiaowe Sound Technology (Shenzhen) Co | 874.3300 | QUF |
Multiple products** | Zhongshan Great-Ears Electronic Tech Co | 874.3300 | QUF |
Multiple products** | Zhongshan Xiaolan Town Senlan Elec | 874.3300 | QUF |
List of OTC and self-fitting hearing aids *additional number product variants not shown **Search the FDA's Establishment Registration & Device Listing for a full list of products using the product code QUF.
If you're following the OTC hearing aid space, you've probably come across ads for Lexie, Sony, and HP branded OTC hearing aids. This is where things get a little more complicated. We've seen a lot of branding partnerships in the hearing aid industry, where OTC hearing aid manufacturers partner up with well known consumer electronic brands to gain market traction.
As an addendum to the table above, here are some of the notable branding partnerships to be aware of:
Device | FDA 510k Cleared Device |
---|---|
Lexie B1 and B2 | Bose SoundControl Hearing Aids |
Sony CRE-C10 | Vibe SF Self-Fitting Hearing Aid (WSA) |
HP Hearing PRO | Nuheara IQbuds 2 PRO Hearing Aid |
Jabra Enhance Plus | GN Store Nord (parent group of Jabra) |
Branding partnerships in OTC hearing aids. These products are all FDA 510k cleared self-fitting DTC and OTC products.
There still may be a number of companies selling hearing aids online that are not actually registered under any of the direct-to-consumer FDA classes. Some may be registered under the product code OSM. OSM is reserved for prescription-based wireless air-conduction hearing aids falling under the old 874.3305 regulation number. Consumers should be aware that, like QUG and QUF products, the FDA does not require OSM products to undergo the type of safety and efficacy testing required of self-fitting OTC hearing aids.
If these companies want to sell their products as OTCs after April 18, 2023—the end of the 6-month grace period after the rules were published in the Federal Register—they will need to comply with the FDA's labeling requirements for OTCs, and if categorized as self-fitting (rather than preset-based), they will also need to cleared by the FDA for safety and efficacy.
A good example of this is Eargo, a company that had products listed under the OSM code. Because their products were Class I or Class II exempt air conduction hearing aids, they had 240 days after the FDA's OTC rules were published in the Federal Register to achieve compliance with the new requirements, including labeling. The company received FDA 510(k) clearance for Eargo 5 and 6 as self-fitting hearing aids on December 22, and Eargo says it is launching Eargo 7 as its third over-the-counter self-fitting device.
In a news release prior to receiving FDA clearance, Eargo's CEO Christian Gormsen stated: "Based on our initial review of the final rule, we believe Eargos can continue to be sold under existing regulations as well as classified as OTC hearing aids, subject to compliance with labeling and other requirements of the final rule. For example, we believe Eargo hearing aids currently on the market are within the FDA’s output and insertion depth limit requirements."
So the bottom line is that some products are permitted to be sold as OTC hearing aids so long as they comply with the current regulatory requirements and gain clearance by April 18.